Skip to main content

Table 2 Demographic features of patients with progressive supranuclear palsy and healthy control subjects

From: Multireceptor fingerprints in progressive supranuclear palsy

 

Patients

Control subjects

p Value

n

16

14

 

Age at death, years

72.5 (6.92)a

75.7 (10.07)

0.34

Male sex, n (%)

9 (56)

9 (64)

0.8

Disease duration, years

8.2 (2.26)a

–

–

Postmortem delay, h, mean (SD)

6.29 (1.21)

7.53 (1.31)

0.01

  1. aThree cases that underwent euthanasia were not included